Filter
1125
Filtered Results: 1125
Text search:
Wolrd
Health
Organisation
(WHO)
Featured
Recommendations
128
New Publications
55
Language
Document type
Studies & Reports
396
Guidelines
340
Manuals
120
Strategic & Response Plan
94
No document type
81
Fact sheets
37
Training Material
32
Situation Updates
9
Resource Platforms
6
Infographics
5
Brochures
4
Online Courses
1
Countries / Regions
Global
100
Russia
34
Kenya
26
Africa
25
Middle East and North Africa
20
Western and Central Europe
19
South Africa
18
Ukraine
15
South–East Asia Region
15
Eastern Europe and Central Asia
15
Latin America and the Carribbean
14
India
12
Ethiopia
11
Syria
11
East and Southern Africa
11
Nigeria
10
Brazil
10
Yemen
10
Western Pacific Region
10
Burkina Faso
8
Mozambique
8
West and Central Africa
8
Eastern Europe
8
Philippines
6
Tanzania
6
Malawi
6
Uganda
5
Sierra Leone
4
Congo, Democratic Republic of
4
Germany
4
Sudan
4
Angola
4
Myanmar / Burma
4
Asia
4
Liberia
3
Senegal
3
Guinea-Bissau
3
Pakistan
3
South Sudan
3
Benin
3
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Nepal
2
Rwanda
2
Indonesia
2
Namibia
2
Eswatini/ Swaziland
2
North Macedonia
2
Lesotho
2
Palestine
2
Mongolia
2
Laos
2
Moldova
2
Kyrgyzstan
2
Kazakhstan
2
Vietnam
2
North America
2
Guinea
1
Mali
1
Morocco
1
Saudi Arabia
1
Ghana
1
Niger
1
Zimbabwe
1
Iraq
1
Zambia
1
Turkey
1
Chad
1
Cambodia
1
Thailand
1
China
1
Bangladesh
1
Central African Republic
1
Argentina
1
Peru
1
Serbia
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
Greece
1
Mexico
1
Sri Lanka
1
Paraguay
1
Fiji
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Uzbekistan
1
Georgia
1
Gabon
1
Turkmenistan
1
Mauritius
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
239
Clinical Guidelines
144
Public Health
111
Women & Child Health
94
Key Resources
59
Capacity Building
23
Pharmacy & Technologies
22
Toolboxes
COVID-19
219
NTDs
76
Planetary Health
74
AMR
73
HIV
69
Caregiver
68
Mental Health
55
TB
50
NCDs
50
Pharmacy
44
Rapid Response
39
Global Health Education
32
Health Financing Toolbox
25
Conflict
24
Disability
18
Refugee
12
Ebola
10
Natural Hazards
7
Cholera
6
Polio
4
Specific Hazards
3
Social Ethics
3
Zika
2
Health Financing
1
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-mak...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals be...
16-24 February 2020
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, ...
The procurement of essential medicines and other health products is a critical function in support of the effective discharge of WHO’s mandate, and WHO<...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progre...
Almost 25% of deaths worldwide could be prevented if the actions in the compendium were fully implemented
This compendium provides a systematic compilation of published guidance from WHO and other UN organizations on ... and environment. Guidance on policies and actions as well as awareness raising and capacity building interventions is presented for all major areas of health and environment. Guidance referring to priority settings for action such as cities and other urban settlements, housing, workplaces and health care facilities is also listed.
For greater practical relevance, each guidance is classified according to principally involved sectors, level of implementation and instruments for implementation.
The compilation of guidance for each area of health and environment or priority setting for action is accompanied, as available, by information on main sources, exposure assessment and existing guideline values. Important tools and further resources are presented alongside.
The WHO global health sector strategy on sexually
transmitted infections, 2016–2021 (1) includes country
milestones for achievement by 2020 and global
targets for achievement by 2030. In add...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO prefe...
Annex 5, WHO Technical Report Series 1010, 2018
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (...) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beijing Wantai’s TB-IGRA and Qiagen QuantiFERON-TB Gold Plus products. This expands the range of tests available to detect TB infection. Full details are provided in this WHO policy statement.
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, late...
This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that ...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guid...
The WHO BioHub Biosafety & Biosecurity: criteria and operational modalities sets out the requirements to which laboratories wishing to receive biological materials as part of this international exchange system should abide, to ensure safe and secure...
The guidance notes describe key actions that policy-makers at national and subnational levels can take in relation to: diagnostic testing for COVID-19, clinical management of COVID-19, meeting targets for vaccination against COVID-19, maintaining infection control measures for COVID-19 in ...-care settings, building confidence through risk communication and community involvement, and ensuring that all health-care workers are aware of the risks of COVID-19.
This guidance note focuses on the following areas: COVID-19 diagnostic testing, clinical management of COVID-19, achieving COVID-19 vaccination targets, maintaining COVID-19 infection control measures in health-care settings, building confidence through risk communication and community engagement, and managing COVID-19 infodemia. This guidance note focuses on risk communication and community engagement in the context of COVID-19.
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation ...
